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The title of this special topic invites us to identify areas in the ﬁeld of IgA biology that
are uncertain or in need of clariﬁcation. The inductive phase of the human intestinal IgA
response has been a controversial area for some years.Therefore, to structure this review,
we have identiﬁed key questions that are debated in this ﬁeld.We have provided explana-
tions of the origins of the uncertainties and have provided our own reasoned answers to
the questions we pose.
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Secretion of a huge quantity of IgA with a diverse antigen-binding
repertoire is essential for the maintenance of intestinal homeosta-
sis and the prevention of mucosal and systemic infection (Conley
and Delacroix, 1987; Brandtzaeg et al., 1999; Wei et al., 2011).
Most of this IgA is secreted by the vast plasma cell population,
which is located beneath the intestinal epithelium throughout the
gastrointestinal tract.
Manyof the questions that continue toperplex thoseworking in
the ﬁeld of mucosal B cell biology, and confuse those outside, relate
to the biology of intestinal B lineage cells prior to terminal differ-
entiation into plasma cells. Problems in providing secure answers
derive from inherent difﬁculties in studying the human intestinal
immune system. Difﬁculties extend beyond the obvious restric-
tions to sampling tissue, and the existence of some basic species
differences (Gibbons and Spencer, 2011). Some difﬁculties are
exempliﬁed by the earliest experiments that deﬁned this ﬁeld. For
example,Gowans andKnight (1964) showed that the thoracic duct
lymph of rats contains a continuous ﬂow of immunoblasts with-
out the need for prior immunization (Gowans and Knight, 1964).
These gut-derived activated cells were destined for the blood.
Adoptive transfer of labeled cells demonstrated that thoracic duct
immunoblasts were pre-programmed to home back to the intes-
tine by selective extravasation through the capillary network. This
demonstrated not only that the intestinal immune system is a dis-
tinct entity, but also that understanding the immunology of the
IgA response would require an appreciation of immune physiol-
ogy and anatomy because multiple anatomically separated sites
and structures were involved, connected by lymph and the blood.
It is particularly difﬁcult to study such a system deﬁnitively in
humans.
Understanding current perception of the intestinal B cell
response initially requires appreciation of the anatomical and
microanatomical sites involved, and the associated terminology
(Brandtzaeg and Pabst, 2004; Brandtzaeg, 2009). The intestinal
immune system can be divided into organized gut-associated
lymphoid tissue (GALT), the lamina propria, the intraepithelial
compartment, and the regional lymph nodes.
Gut-associated lymphoid tissue (Figure 1) is organized lym-
phoid tissue with discrete B and T cell zones, that is, by deﬁnition
intimately associated with a specialized follicle associated epithe-
lium (FAE). The “microfold” or “M” cells of the FAE selectively
sample particulate antigen from the gut lumen and transport it
to the underlying lymphoid tissue (Chabot et al., 2006) forming a
discriminatory gatekeeper function, but also a connectionwith the
luminal microbiota. The Peyer’s patches are aggregates of GALT
that are most concentrated in the terminal ileum. Isolated follicles
of GALT as will be discussed below are also located throughout
the small and large intestines.
In contrast, the laminapropria comprises diffuse connective tis-
sue with a lymphoid component that includes largely effector cells;
both cytokine-producing T cells and plasma cells (Farstad et al.,
2000). The vast majority of B cells in lamina propria are CD19+,
CD20−, and these cells are almost certainly the extravasated
immunoblasts en route to terminal differentiation to plasma cells.
The lamina propria is sited below an epithelial barrier, which in
contrast to the FAE is secured by tight junctions and covered by a
layer of mucins and microbicidal molecules on the luminal aspect
(Turner, 2000).
The intraepithelial lymphoid compartment (other than theFAE
associated lymphocytes) does not include many B cells, and is not
relevant to this review. The mesenteric lymph nodes on the other
hand contain and abundance of active B cells and the scale of
their involvement in human intestinal immunity is not known
(Figure 2).
A major goal in human intestinal immunity must be to deduce
how the IgA response can be harnessed for mucosal vaccination.
Understanding the rules that govern the generation and dissemi-
nation of the antigen-speciﬁc plasma cells in the intestine would
move us considerably further toward that goal, though there are
still many areas that lack clarity. Table 1 comprises a list of current
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FIGURE 1 | Paraffin sections of human appendix stained to detect IgA
(brown). Gut-associated lymphoid tissue (GALT) is boxed. GALT is
comprised mostly of B cells and contains a prominent germinal center of
dividing B cells (dotted circle). The epithelial barrier between the GALT and
the intestinal lumen, marked with a dotted line, is the FAE. Lamina propria
(Lp) is boxed either side of GALT. The lamina propria includes abundant
effector cells including plasma cells (arrowed) Unlike the epithelium
adjacent to GALT, crypt epithelium of the lamina propria contains IgA that is
in the process of being transported to the intestinal lumen (arrow heads).
questions that relate to the human intestinal immune response
that might be answered unambiguously in the near future. The
questions are accompanied by our own simple best answers. The
ﬁnal column is our measure of faith in our answer. Our rea-
soned responses to the questions and rationale behind the answers
comprise the text of this review.
DO THE EVENTS THAT INITIATE THE HUMAN IgA RESPONSE
OCCUR EXCLUSIVELY IN GUT-ASSOCIATED LYMPHOID
TISSUE?
It is clear from simple histological observations that GALT is an
inductive site for intestinal B cell responses. The Peyer’s patches
invariably have prominent germinal centers of dividing B cells.
Dividing cells are also apparent in the large marginal zone that
forms the outermost B cell area of GALT (Boursier et al., 2005).
Suggestion that lamina propria might be an inductive site fol-
lowed a high proﬁle study of cell suspensions prepared from the
intestines of mice with the Peyer’s patches removed (Fagarasan
et al., 2001). This work identiﬁed that the enzyme activation-
induced cytidine deaminase (AID), the essential catalyst of class
switch recombination and somatic hypermutation, was present in
the isolates. Several years later, it was proved that GALT is required
for the IgA response, and that the features of the inductive phase
of the IgA response ascribed to lamina propria cells was in fact
a consequence of contamination of the isolates by cells from the
organized GALT in isolated lymphoid follicles (ILF). The isolated
follicles are not macroscopically visible, and are developmentally
FIGURE 2 | Paraffin sections stained to detect (A) IgA1 and (B) IgA2.
Cells with cytoplasmic immunoglobulin of both subclasses can be
observed in germinal centers (dotted circles) demonstrating that the
mesenteric nodes could be classiﬁed as a non-GALT site of induction for
IgA responses. The presence of cells with cytoplasmic IgA2 in mesenteric
nodes (arrows) also demonstrates that switching to IgA2 is not only a
feature of terminal differentiation in the colonic lamina propria.
independent of the Peyer’s patches (Tsuji et al., 2008; Lindner et al.,
2012). Meanwhile the concept of lamina propria as an inductive
site had gatheredmomentumandhas been documented in reviews
(Cerutti, 2008a; Suzuki and Fagarasan, 2009).
It has been suggested that IgA class switch recombination to
IgA2 can occur in human colonic lamina propria, driven by the
IgA switch factor a proliferation-inducing ligand (APRIL) pro-
duced by epithelia in response to TLR5 ligation by colonic luminal
bacteria (He et al., 2007). Although this idea provides an elegant
explanation for the relatively higher frequency of plasma cells syn-
thesizing the IgA2 subclass in colon (Kett et al., 1986; Kett and
Brandtzaeg, 1987), it has been contested by groups that give full
consideration to the lymphoid microenvironments in intestine.
The study of both mouse and human lamina propria cells that
were sampled from tissue sections in situ, or isolated plasma cells
did not detect the expression of AID in lamina propria of large or
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Table 1 | Outstanding questions in human IgA immunobiology.
Question Authors’ best
guess answer
Degree of certainty
in answer (%)
Do the events that initiate the human IgA response, occur exclusively in gut-associated lymphoid tissue? Yes 90
Is there an equivalent of murine cryptopatch precursor of ILFs in humans? No 95
Can gut-associated lymphoid tissue be acquired in response to bacterial antigens in humans? Yes 100
Are there T cell dependent andT cell independent routes to IgA production in man? Yes 95
Are intestinal T cell dependent IgA responses, necessarily dependent on conventional cognate
interactions in humans?
No 60
Do innate receptors have any role in driving the human mucosal IgA response? Yes 100
Might germinal centers be involved in both T cell dependent andT cell independent IgA responses in
humans?
Yes 95
Are there differences in the induction of IgA responses that seed the small bowel and the colon? Yes 70
Is the human intestinal IgA response antigen speciﬁc? Yes 100
Is light chain drifting a feature of the IgA response? Yes 100
Is there local proliferation of plasma cell precursors in the human intestinal lamina propria? No 90
Are human intestinal IgA plasma cells long lived? Yes 90
small intestine (Boursier et al., 2005; Bergqvist et al., 2006, 2010;
Di Niro et al., 2012). Class switch recombination also requires cell
division; a process that has not been observed in lamina propria
cells directly (Boursier et al., 2005; see Is there Local Proliferation
of Plasma Cell Precursors in the Human Intestinal Lamina Pro-
pria?). Cells in germinal centers of mesenteric lymph nodes can
express IgA2, again, consistent with class switch to IgA2 prior to
homing to the lamina propria environment (Figure 2).
It was suggested that the lamina propria B cell response may be
initiated by antigens sampled by dendritic cells (DC) that extend
processes through the epithelium (Rescigno et al., 2001; Niess
et al., 2005). It was also suggested that the lamina propria B cell
response in mice might involve the B1 lineage (Kroese et al., 1989).
However, it is now apparent that the lamina propria in mice and
humans may not be so different, with most having features exclu-
sively of effector niches. The DCs that take up antigen from the
lumen do not mediate antigen presentation in the lamina pro-
pria, but transfer antigen to DCs that mediate their function in
the mesenteric lymph nodes (Pabst et al., 2007; Pabst and Mowat,
2012).
The exclusivity of GALT as an inductive site is not correct if the
contribution of the mesenteric lymph node is considered, hence
the lack of certainty in Table 1. GALT is deﬁned in part by its rela-
tionship to the intestinal epithelium; so mesenteric lymph node
is therefore potentially a non-GALT inductive site (Brandtzaeg
and Pabst, 2004). Human mesenteric nodes are immunologically
active structures containing germinal centers that could represent
initiation or ampliﬁcation of human intestinal B cell responses
(Figure 2). It would most accurate to say that the human IgA
response is generated in organized lymphoid tissue, and that the
lamina propria is not an inductive site.
IS THERE AN EQUIVALENT OF MURINE CRYPTOPATCH
PRECURSOR OF ILFs IN HUMANS?
Cryptopatches of mice are small isolated clusters of lymphoid
progenitors located around the base of the small intestinal crypts
(Kanamori et al., 1996). Engagement of epithelial NOD1 innate
receptors by bacteria from the intestinal lumen initiates the
development of ILF from cryptopatch precursors (Bouskra et al.,
2008). GALT acquired in this way in mice exists as single isolated
follicles that are invisible to the naked eye, rather than the macro-
scopically visible clusters of lymphoid tissue that comprise murine
Peyer’s patches.
One problem in addressing the question of whether humans
have cryptopatches or even a direct equivalent of ILF is that GALT
in humans, in general, is either invisible or just visible to the naked
eye. GALT can be visualized from the luminal aspect in humans
by injecting dye into the mucosa, by ﬁxation or by using magni-
ﬁcation (Cornes, 1965). GALT in normal human small intestine
can exist as large clusters, small clusters or isolated follicles in the
small bowel and each of these categories appears to be structurally
and developmentally equivalent (Figure 3), and not necessarily
to be associated differently with the microbiota in the intestinal
lumen.
In their search for cryptopatches, Moghaddami et al. (1998)
described lymphocyte ﬁlled villi; clusters of lymphocytes within
a villus structure. The signiﬁcance of these structures, that
are not rare, remains unknown. The current consensus is that
humans do not have cryptopatches (Moghaddami et al., 1998;
Brandtzaeg, 2010), but it is possible that they exist during a
small window in time just after birth, though they are still to be
discovered.
CAN GUT-ASSOCIATED LYMPHOID TISSUE BE ACQUIRED IN
RESPONSE TO BACTERIAL ANTIGENS IN HUMANS?
Probably the clearest example of acquisition of GALT in humans
in response to bacteria is the acquisition of GALT in the stomach
in response to the gastric bacterial pathogen Helicobacter pylori
(Wotherspoon et al., 1991). Normal stomach is rich in mucus
and acid and is generally sterile in health (Williams, 1992; Mob-
ley, 1996). The lamina propria underlying the gastric epithelium
contains a sparse inﬁltrate of lymphoid and myeloid cells and
there is no GALT. H. pylori is able to colonize the stomach by
neutralizing the acidic microenvironment by the production of
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FIGURE 3 | (A,B) Frozen sections of human fetal intestine of 22weeks of
gestation. (A) Is stained with CD3 (T cells in brown) and CD20 (B cells in
blue). (B) Is stained for CD3 (T cells in brown) and CD5 (B cells in blue since
human fetal B cells are CD5+). Follicles in clusters in (A) or as ILF in (B) are
the same in terms of the cellular composition and stage of development.
Parafﬁn sections of human intestine at 4 days old stained for cytoplasmic
IgM. (C) Illustrates a cluster of follicles in a Peyer’s patch and (D) illustrates
a single follicle that could be classiﬁed as an ILF. In (C,D), cytoplasmic
IgM+ cells can be identiﬁed in the germinal center and on the periphery of
the follicle and they appear very similar. There was very little IgA apparent in
sections of either in stained serial sections. These images demonstrate that
in human ileum there is no apparent developmental difference between
follicles in clusters and isolated lymphoid follicles.
ammonia. Infection with H. pylori is relatively common and the
gastritis associated with H. pylori infection invariably includes the
acquisition of GALT.
Helicobacter pylori infection may be a causative contributor
to gastric malignancy including lymphoma of mucosa-associated
lymphoid tissue (MALT; Wotherspoon et al., 1993). Therefore
pathologists are acutely aware of the changes in the gastric mucosa
and the lymphoid cells it contains in response to H. pylori
infection. If cryptopatches were involved in the development of
acquired ILFs in human stomach in response to bacteria, they
would almost certainly have been noticed. However,murine stom-
ach is not necessarily equivalent to murine intestine in the biology
of cryptopatches (Ishikawa et al., 1999) and this does not reﬂect
on the issue of human cryptopatches as a whole, which remains
unclear.
ARE THERE T CELL DEPENDENT AND T CELL INDEPENDENT
ROUTES TO IgA PRODUCTION IN MAN?
The identiﬁcation of T cell independent contributions to the
human intestinal IgA response would not have been possible with-
out examples in human disease phenotypes. For example, the
subset of patients with hyper-IgM syndrome who have muta-
tions in CD40 have intestinal IgA responses despite the inability
to recruit cognate T cell help through CD40/CD40L interaction.
This is also true in CD40−/− mice that have IgA plasma cells
(Ferrari et al., 2001; Bergqvist et al., 2006, 2010; He et al., 2007;
Cerutti et al., 2011). Consistent with a lack of germinal center
formation however, for which cognate T cell interaction remains a
prerequisite, there are no mutations in the immunoglobulin heavy
chain variable region genes (IGHV; Bergqvist et al., 2006, 2010).
A further example demonstrating that the IgA response is not
necessarily T cell dependent in humans is the presence of an IgA
response in individuals with severe T cell depletion or loss of ger-
minal centers as a consequence of HIV infection (Levesque et al.,
2009), though this response may be reduced, especially in the IgA2
subclass (Schneider et al., 1996; He et al., 2007).
Dendritic cells can produceAPRIL that can support class switch
recombination to IgA in the absence of T cell derived CD40 lig-
ation (Fayette et al., 1997; Litinskiy et al., 2002; Cerutti, 2008b).
Despite its name,APRIL is not speciﬁcally a B cell activating factor
and its function as a switch factor in models of APRIL class switch
function generally include additional elements such as an initiator
of cell division and cytokine, for example IL4 (Hardenberg et al.,
2007). In contrast, T cell dependent class switch to IgA involves
ligation of CD40 on B cells by T cells expressing CD40L and bind-
ing of the cytokine TGFβ to its receptor on B cells (McIntyre et al.,
1995; Zan et al., 1998).
It has been suggested, based on mouse models, that T cell
dependent IgA responses are initiated in Peyer’s patches, whereas
T cell independent IgA responses occur in ILF (Suzuki and
Fagarasan, 2009), though this may not be exclusive, particularly
in the context of infection with viruses expressing highly repet-
itive antigenic determinants on their envelopes or capsids. The
early murine immune response to rotavirus infection includes a
T-independent IgA response (Franco and Greenberg, 1997; Van-
Cott et al., 2001; Blutt et al., 2008), driven by a B cell/DC axis
in Peyer’s patches (Blutt and Conner, 2010). In humans, func-
tional differences between Peyer’s patches and ILFs are not yet
apparent; both contain APRIL-secreting cells and cells express-
ing the receptors for APRIL; TACI; and BCMA (Barone et al.,
2009). The colonic isolated follicles (lymphoglandular complexes;
O’Leary and Sweeney, 1986)may have large, small, or undetectable
germinal centers, and it is possible that colonic GALT may be dif-
ferent to GALT in the small bowel by having less dependence on
cognate B cell/T cell interactions and germinal center formation
(Garside et al., 1998). If conﬁrmed, this may suggest a new avenue
for mucosal vaccine design, facilitating induction of high afﬁnity
IgA+ B cells independent of strict cognate B cell/T cell signaling.
Currently, enteric vaccine designs are largely focused onmore con-
ventional approaches to harness T-dependent B cell pathways with
the goal of stimulating IgA memory B cell responses, as illustrated
by the live attenuated Shigella vaccines progressing through the
clinic (Simon et al., 2011a). Sub-unit enteric vaccines can contain
the outer membrane polysaccharide moiety of lipopolysaccha-
ride (LPS; O-Ag), a major protective antigen of many Enter-
obacteria (Svenson et al., 1979; Rasolofo-Razanamparany et al.,
2001; Levine et al., 2007). As such, polysaccharide antigens may
purely driveT-independent IgA responses, though these areweakly
immunogenic in infants (reviewed in Pollard et al., 2009; Renz
et al., 2011). Nonetheless, considerable evidence demonstrates
that conjugation of O-Ag haptens to protein carriers success-
fully drives potent T-dependent responses both in mice (Phalipon
et al., 2006; Simon et al., 2011b) and in humans (Passwell et al.,
2003).
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ARE INTESTINAL T CELL DEPENDENT IgA RESPONSES
DEPENDENT ON CONVENTIONAL COGNATE INTERACTIONS
IN HUMANS?
Conventional T cell dependent B cell responses that result in the
formation of germinal centers initially involve the endocytosis of
antigens bound by the B cell receptor and presentation of peptides
derived from them to pre-primed T cells (Garside et al., 1998).
The ﬁrmest evidence for a lack of requirement for such cognate
interaction in mucosal responses stems from a study in which
the requirement for tonic signaling for B cell survival through
the B cell receptor in a murine model was substituted by the latent
membrane protein of Epstein Barr virus (EBV; Casola et al., 2004).
These mice were unable to endocytose and present antigen, and
therefore could not recruit T cell help and germinal centers did
not form in the systemic lymphoid tissues. Interestingly however,
germinal centers did form in the Peyer’s patches and these were T
cell dependent and also dependent on the luminal microﬂora.
Is there any evidence of possible disconnectivity between B
cell and T cell speciﬁcity that also relates to humans? Human
MALT lymphomas are malignancies of mucosal marginal zone
B cells. The tumor cells are intimately associated with germinal
centers and can enter, divide and differentiate in germinal centers
(Isaacson and Spencer, 1987). The immunoglobulin speciﬁcities
of MALT lymphomas have now been studied by many groups
and a dominant reactivity with autoantigens is a consistent fea-
ture (Hussell et al., 1993; Greiner et al., 1994; Craig et al., 2010).
The development of MALT lymphomas in general is associated
with infection of the gastric mucosa with the bacterial pathogen
H. pylori (Wotherspoon et al., 1993). The T cells have been shown
to proliferate in response to the stimulating bacterial strains pre-
sented appropriately, but bizarrely there is no evidence that the T
cell reactivity and B cell reactivity overlap in a way consistent with
cognate interaction (Hussell et al., 1996). It is therefore possible
that participation in human intestinal germinal center associatedB
cell responses is not dependent on cognate interactions. However,
the lack of germinal centers in CD40−/− mice demonstrates that
CD40 itself remains absolutely central to GALT germinal center
initiation (Bergqvist et al., 2006).
DO INNATE RECEPTORS HAVE ANY ROLE IN DRIVING THE
HUMAN MUCOSAL IgA RESPONSE?
They almost certainly do, as suggested by reports of increased inva-
sive Salmonella and Shigella in patients with inborn errors in the
signaling effectors IRAK-4 and MyD88 downstream of the TLRs
(Picard et al., 2010). The absence of several enteric viral infections,
may simply suggest that RIG-I-like helicases (RLRs) andNOD-like
receptors (NLRs) may provide a compensatory role in MyD88 and
IRAK-4 deﬁcient individuals.Whether TLR,NLR,or RLRs operate
any differently in the intestine compared to in peripheral systemic
lymphoid tissues or tonsil is unknown.
The expression of innate TLR receptors by human and mouse
B cells is very different, and it is not possible to draw any parallels
in this respect. The most notable difference is the lack of TLR4
expression by human B cells and therefore inability to respond
to LPS (Bourke et al., 2003; Wagner et al., 2004). In contrast to
humans, LPS is the classic TI-1 B cell antigen that has been part
of the murine B cell immunologists’ toolbox for many years. The
ability to respond to LPS by innate B cell subsets is a potentially
important property in the gut and enabled identiﬁcation of a func-
tional link between murine peritoneal B1 and intestinal responses
(Murakami et al., 1994).
Probably the most relevant and functionally important B cell
innate receptor known in humans is TLR9.Whilst being extremely
important to B cell function, is not known to have a speciﬁc role at
mucosal surfaces. A recent study showed that there appeared to be
no difference between the involvement of TLR9 in mucosal ver-
sus systemic responses (Barone et al., 2011). Interestingly, human
tonsillar B cells are reported to undergo T-independent IgA pro-
duction through an innate TLR3 BAFF dependent pathway (Xu
et al., 2008). Whether intestinal infections with RNA viruses such
as rotavirus or treatment of intestinal B cells with dsRNA trigger
this TLR3 driven T-independent pathway is currently unknown.
MIGHT GERMINAL CENTERS BE INVOLVED IN BOTH T CELL
DEPENDENT AND T CELL INDEPENDENT IgA RESPONSES IN
HUMANS?
Although class switch recombination to IgA can be T cell inde-
pendent or T cell dependent as described above (Zan et al., 1998;
Litinskiy et al., 2002; Kaminski and Stavnezer, 2004), high rates of
somatic hypermutation appear to be germinal center dependent
(Bergqvist et al., 2006).Almost without exception, IgA plasma cells
of healthy humans have high frequencies of mutations in IGHV, so
that a germinal center independent contribution to the plasma cell
population is not apparent (Boursier et al., 1999; Dunn-Walters
et al., 2000; Di Niro et al., 2010). It is likely that the boundaries
between T cell dependence and independence are blurred in vivo.
In health, B cells are never truly remote from T cells or their lym-
phokines. The intestinal immune system is very ﬂexible and the
plasticity in the system probably testiﬁes to its importance (Gib-
bons andSpencer,2011).However, features that are observedwhen
the system is compromised may not make a major contribution in
health when the optimal paths and paths of least resistance would
presumably be favored. T cell-independent responses are certainly
possible, but it is not possible to gage the extent to which they
actually occur in healthy humans.
ARE THERE DIFFERENCES IN THE INDUCTION OF IgA
RESPONSES THAT SEED THE SMALL BOWEL AND THE
COLON?
The GALT in human colon is different in structure to that in the
small intestine. It tends to arise on the serosal side of themuscularis
mucosae and to extend through a gap in the muscularis toward the
surface epithelium forming a narrow FAE (O’Leary and Sweeney,
1986). The colonic FAE tends not to protrude into the intesti-
nal lumen as FAE does in the small bowel (Spencer et al., 2009).
Colonic GALT in humans was reported to tend not to include the
large germinal centers observed in small intestinal GALT, though
the same paper commented that the frequency of germinal centers
in lymphoglandular complexes was more frequent in specimens
with malignant growth (O’Leary and Sweeney, 1986).
The plasma cells that home to the colonic mucosa are known
to have a greater tendency to migrate toward CCL28 through
detection of this colonic epithelium derived chemokine by CCR10
(Kunkel et al., 2000). This contrasts with plasma cells destined for
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the small bowel that tend to express CCR9 that mediates move-
ment toward CCL25 (Pan et al., 2000; Morteau et al., 2008). It is
not known if these chemokine receptors that determine the site of
extravasation of plasma cell precursors are induced differently in
different microenvironments, though this would seem likely.
The human intestinal plasma cell population includes many
clones of widely disseminated cells along the intestine. Early stud-
ies that visualized the spread of human plasma cell clones by
microdissection of small numbers of cells identiﬁed clonal identity
by sequencing IGHV saw that clones of plasma cells could span the
small and large intestine, but that it wasmore common for clonally
related groups of plasma cells to be identiﬁed in either small bowel
or colon (Dunn-Walters et al., 1997; Holtmeier et al., 2000). This
is consistent with the distribution of chemokine directed clones
as described above. This pattern of plasma cell dissemination has
now been elegantly conﬁrmed through deep sequencing of the
mouse IgA immunoglobulin repertoire. The elegant piece of work
demonstrates the clonal spread of plasma cells, focused but not
exclusive to either the small bowel or the large bowel (Lindner
et al., 2012).
A difference between the plasma cells in human colon and those
in the small intestine is the relatively high frequency of plasma cells
secreting the IgA2 rather than IgA1 subclass of IgA. As discussed
above (see Do the Events that Initiate the Human IgA Response
Occur Exclusively in Gut-Associated Lymphoid Tissue?) it has
been suggested that this switch to IgA2 may happen once cells
have homed to the lamina propria (He et al., 2007). However, cells
switched to IgA2 have been observed in colonic GALT (Barone
and Spencer, 2010) and it is therefore possible that the switch to
IgA2 and induction of CCR10 expression may both be features
of induction of a colonic B cell response. This inductive process
might be promoted by the high colonic bacterial load (Kett et al.,
1995). It is also possible that bacterial load could induce factors
such as CCL28 that recruit effector cells propagated in the colonic
GALT.
IS THE HUMAN INTESTINAL IgA RESPONSE ANTIGEN
SPECIFIC?
IgA antibodies to polio were identiﬁed in intestinal secretions
of immunized individuals, but not serum (Ogra and Karzon,
1969). This study was a major contributor to the establishment
of mucosal immunology as a discipline. Polyspeciﬁc antibodies
that bind to multiple antigens were also identiﬁed in secretions
(Wijburg et al., 2006). However these studies did not allow the
analysis of speciﬁcity at a single cell level. Since then, two develop-
ments have made a huge and precise contribution to our under-
standing of mucosal B cell speciﬁcities. The ﬁrst is based on the
engineered expression of immunoglobulin heavy and light chain
sequences that had been expressed by intestinal plasma cells or
their precursors (Weitkamp et al., 2005, 2006; Di Niro et al., 2010;
Benckert et al., 2011). Such studies have permitted the in vitro
expression of immunoglobulins and have identiﬁed that human
intestinal plasma cells have pathogen speciﬁcity, but they are also
reactive with a range of autoantigens in assays including the bind-
ing of antibodies to the HEpC cell line, normally used in the
diagnosis of autoimmune diseases. The second method is depen-
dent on the expression of surface immunoglobulins by intestinal
plasma cells (Di Niro et al., 2010). This has permitted the quantiﬁ-
cation and isolation of cells binding ﬂuorescence-tagged rotavirus
antigens by ﬂow cytometry, as well as the subsequent analysis of
expressedprotein followingheavy and light chain gene sequencing.
Antigen speciﬁcity within the human IgA response and persistent
production of speciﬁc antibodies over time (Mesin et al., 2011)
are encouraging observations that imply that effective intestinal
vaccination is a totally realistic goal.
IS LIGHT CHAIN DRIFTING A FEATURE OF THE IgA
RESPONSE?
Revision of light chains expressed IgA plasma cells is a feature
of the human intestinal plasma cell response that is not widely
appreciated and the factors regulating it are not known. Biases in
gene rearrangements at the lambda loci of IgA plasma cells and
their precursors are extreme and do not mirror the rearranged
IGL gene proﬁle of IgD+ mature naïve B cells (Su et al., 2008).
A recent study into the origin of distinct memory B cell subsets
describe a drift from the expected 60:40% κ:λ light chain iso-
type ratio in humans toward dramatically increased expression
of lambda light chains (up to 80% Ig λ+ cells) by IgA+ mem-
ory B cells of the gut (Berkowska et al., 2011). This resonates the
need for ongoing Ig gene rearrangements within a subset of cells
required to continually diversify in response to the complex array
of intestinal antigens. Each immunoglobulin heavy chain locus
cannot rearrange more than once because the recombination sig-
nal sequences that ﬂank the D segments are deleted by the initial
rearrangement event. This is not a problem for the IGL rearrange-
ments that do not involve D segments. The kappa locus can be
inactivated by the kappa deleting element so that it is not always
available for secondary rearrangements. The lambda locus how-
ever is not constrained in either of these ways and appears to
be able to be sequentially activated and to permit drifting in the
rearranged repertoire (Spencer et al., 2009). The detection of RAG
genes in human GALT certainly supports this notion, though how
this is regulated is unknown (Su et al., 2008).
IS THERE LOCAL PROLIFERATION OF PLASMA CELL
PRECURSORS IN THE HUMAN INTESTINAL LAMINA
PROPRIA?
Some early studies of rat intestine involved the surgical creation of
isolated circles of intestine, so-calledThiryVella loops. The isolated
loops were separated from the rest of the intestine, through which
the luminal contents would transit (Husband and Gowans, 1978).
If antigen was introduced into the loops there was a tendency for
antigen-producing cells to localize there and increase in number.
Cells that homed to loops containing no speciﬁc challenge disap-
pearedwith time. Thiswas interpreted as local proliferation of cells
that homed to the lamina propria in response to the challenging
antigen. It is now known however that such expansion was likely
to have occurred in ILF within the loop. Cell division cannot be
detected in isolated lamina propria plasma cells by immunohis-
tochemical methods (Boursier et al., 2005). However, it has been
claimed that clonal expansions of plasma cells within intestinal
microenvironments is evident by identiﬁcation of local groups
of related IGHV sequences by PCR (Yuvaraj et al., 2009). In this
model, the isolated IGHV sequences are identiﬁers of clones of
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cells. Other groups claim that such ﬁndings are a consequence
of dissemination of large clones of cells throughout the intestine
(Boursier et al., 2005).
A recent thorough and detailed analysis of mouse IgA plasma
cell repertoire has modeled the distribution of plasma cell clones
and asked whether this actual distribution ﬁts a mathematical
model that includes rounds of cell division after homing of plasma
cell precursors to the lamina propria. This study concluded that
the data best ﬁts a model where plasma cell precursors home and
differentiate either without or with very little cell division (Lind-
ner et al., 2012). It is possible that cell division occurs during a
narrow window of time or that it is very slow over a long time so
that it is rarely observed. The expression of surface immunoglobu-
lin by human intestinal plasma cells and their precursors certainly
implies that they potentially remain receptive to external stimuli
that could initiate cell activation (Di Niro et al., 2010).
ARE HUMAN INTESTINAL IgA PLASMA CELLS LONG LIVED?
A recent study by MacPherson’s team using mice colonized by
live bacteria with a ﬁnite life span (Hapfelmeier et al., 2010) has
shown that intestinal plasma cell niches will ﬁll according to cur-
rent challenges and will be replaced depending on changes in the
contents of the intestinal lumen. The question of plasma cell life
span in humans was difﬁcult to consider, until recent advances
in expression of immunoglobulin variable region genes derived
from plasma cells as immunoglobulin proteins. This enabled the
detection of plasma cells secreting rotavirus speciﬁc antibodies
when there was no recent history of rotavirus infection, clearly
demonstrating long-term plasma cell survival (Di Niro et al., 2010;
Mesin et al., 2011). It remains unknown whether rotavirus infec-
tions might be subclinical and undetected, or if antigen might
be retained, but nevertheless this insight is important because it
shows that clinically relevant speciﬁc responses can bemaintained.
Gene expression proﬁles of human intestinal plasma cells show
them to have intermediate properties between short- and long-
lived plasma cell populations (Medina et al., 2003). A study of
whole biopsies in organ culture have identiﬁed that intestinal
plasma cells may have a longer lifespan in situ than in isolation
(Mesin et al., 2011). APRIL can support plasma cell survival in
bone marrow (Belnoue et al., 2012), and APRIL produced by
macrophages and epithelial cells is likely to abundant in lamina
propria (Barone et al., 2009). Blocking APRIL binding to its recep-
tor blocks lamina propria plasma cell survival in in vitro organ
cultures, implying that sustaining long-term plasma cell survival
would be dependent on the local supportive microenvironment
(Mesin et al., 2011).
CONCLUSION
IgA B cell responses to gut mucosal antigens: Do we know it all?
The answer is clearly no. In this review we identiﬁed what we con-
sidered to be 12 important questions relating to this topic, but we
were unable to answer the majority with any certainty. It is also
highly unlikely that all researchers in this ﬁeld would agree fully
with our deductions. What is clear however is that the intesti-
nal plasma cell response is geared toward generation of repertoire
diversity in response to challenge from the luminal microbiota.
Superimposing speciﬁcity and memory onto such a system is a
major challenge for intestinal vaccine design.
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